Brian James Potter, MDCM, SM, FRCPC

Dr. Brian James Potter obtained his Doctor of Medicine (MDCM) degree from McGill University in 2004.

He completed his training in Internal Medicine and Cardiology at the Université de Montréal, earning his certification in Cardiology in 2011.

To further develop his expertise in interventional cardiology, he completed one year of advanced training in interventional cardiology at the CHUM, followed by a second fellowship year at Beth Israel Deaconess Medical Center in Boston, a teaching hospital affiliated with Harvard Medical School. He completed this subspecialty training in 2014.

In parallel with his clinical training, he earned a Master of Science (SM) in Epidemiology and Biostatistics from the Harvard T.H. Chan School of Public Health in 2013. He also completed additional training in decision analysis and cost-effectiveness evaluation of medical interventions at Harvard’s Center for Health Decision Science and at Brigham and Women’s Hospital in Boston.

Academic Appointments and Leadership Roles

Dr. Potter is an Assistant Clinical Professor in the Department of Medicine at the Université de Montréal.

At the Centre hospitalier de l’Université de Montréal (CHUM), he holds several leadership positions:

• Director of the Percutaneous Heart Failure Interventions Program;
• Co-Director of the Complex High-Risk Percutaneous Coronary Intervention (CHIP) Program;
• Director of Cardiac Intensive Care Research and Quality Improvement;
• Principal Scientist at the CHUM Health Innovation and Evaluation Hub.

Clinical Practice

Dr. Potter has been practicing as an interventional cardiologist at the CHUM Cardiovascular Center since 2014.

His clinical practice focuses primarily on complex coronary interventions, mechanical circulatory support devices, acute cardiac care, and percutaneous interventions for patients with advanced heart failure.

Clinical and Research Interests

Dr. Potter’s clinical and scientific activities focus primarily on the optimization of cardiovascular resources and therapies, particularly in the fields of acute cardiac care, interventional cardiology, and heart failure. His research expertise includes clinical studies, retrospective analyses, decision science, and cost-effectiveness evaluation applied to cardiovascular medicine. An active researcher, he is the author or co-author of numerous scientific publications in these areas.

His principal areas of interest include:

• percutaneous interventions for chronic and acute heart failure;
• management of cardiogenic shock and hemodynamic support devices;
• long-term ventricular assist devices;
• complex and high-risk coronary interventions;
• quality improvement in interventional cardiology;
• health technology assessment;
• clinical epidemiology and pharmacoepidemiology;
• mobile technology-enabled cardiac rehabilitation.